R adiologists play a pivotal role in cancer care through imaging for the purposes of screening, diagnosis, treatment planning, and surveillance. Additionally, image-guided tissue biopsies performed by radiologists allow for more specific diagnosis and the ability to molecularly characterize tumor cells. Radiologists are also involved in cancer treatment as interventional radiologists deliver minimally invasive local-regional therapies and nuclear medicine physicians administer radionuclide therapy. As discussed by Hricak (1), there are many exciting developing advancements in the field of radiology in the context of precision oncology. Although characterizing physiologic and molecular features of tumors through imaging has traditionally been limited to enhancement characteristics and metabolism, deeper tumor characterization is now possible through molecular imaging for treatment selection, dose finding, and data acquisition on tumor metabolism through nuclear medicine and MR spectroscopy. These innovations, combined with the integration of artificial intelligence and the emerging fields of theranostics and radiomics, are just a few of the ways that radiologists are expanding their contributions and adding value to the care of the patient with cancer (1,2).The emergence of precision medicine and personalized cancer treatment based on genetic analysis of tumor tissue over the past few decades has resulted in more specific treatment options. While tumor cell receptors, driver mutations, and treatment-susceptible alterations allow for tailored treatment selection, cancers continue to adapt through genetic and epigenetic alterations and acquire resistance to therapy (3). Intratumor heterogeneity
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.